Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyPierre‐François Laterre, Andreas Bergmann, Massimo Antonelli et al.|Critical Care|2018Cited by 134
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Matthieu Legrand, Xavier Wittebole et al.|Kidney International Reports|2018Cited by 108
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92
Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill PatientsFrançois Dépret, Matthieu Legrand, Alain Cariou et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 79
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlexandre Mebazaa, Alice Blet, Benjamin Deniau et al.|Critical Care|2021Cited by 79